Lisa Feng - 12 Nov 2025 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Signature
/s/ Mark McKechnie, Attorney-in-Fact for Lisa Feng
Issuer symbol
ACMR
Transactions as of
12 Nov 2025
Net transactions value
-$829,950
Form type
4
Filing time
14 Nov 2025, 16:30:28 UTC
Previous filing
09 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Feng Lisa Chief Financial Officer of ACM Research (Shanghai), Inc., a subsidiary of the Issuer C/O ACM RESEARCH, INC., 42307 OSGOOD ROAD, SUITE I, FREMONT /s/ Mark McKechnie, Attorney-in-Fact for Lisa Feng 14 Nov 2025 0001779777

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACMR Class A Common Stock Options Exercise $84,000 +15,000 +30% $5.60 65,001 12 Nov 2025 Direct F1
transaction ACMR Class A Common Stock Sale $491,400 -15,000 -23% $32.76 50,001 12 Nov 2025 Direct F2
transaction ACMR Class A Common Stock Options Exercise $84,000 +15,000 +30% $5.60 65,001 13 Nov 2025 Direct F3
transaction ACMR Class A Common Stock Sale $506,550 -15,000 -23% $33.77 50,001 13 Nov 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACMR Stock Option Options Exercise $0 -15,000 -50% $0.000000 15,000 12 Nov 2025 Class A Common Stock 15,000 $5.60 Direct F1, F4
transaction ACMR Stock Option Options Exercise $0 -15,000 -100% $0.000000 0 13 Nov 2025 Class A Common Stock 15,000 $5.60 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 On November 12, 2025, the reporting person exercised a previously issued stock option to purchase 15,000 shares of Class A Common Stock of the Issuer.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2025.
F3 On November 13, 2025, the reporting person exercised a previously issued stock option to purchase 15,000 shares of Class A Common Stock of the Issuer.
F4 The option is fully vested and exercisable.

Remarks:

Chief Financial Officer of ACM Research (Shanghai), Inc., a subsidiary of the Issuer